Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Supplemental digital content is available for this article. Use Caution/Monitor.lorazepam, clozapine. lorazepam and ziprasidone both increase sedation. NOTES: Lifestyle changes such as starting a stress reduction program may increase the effectiveness of this medication. Monitor Closely (2)lorazepam, clozapine. Keywords
Monitor Closely (1)lorazepam increases and armodafinil decreases sedation. lorazepam and morphine both increase sedation. For information about enrolling in MedicAlert, call 1-888-633-4298 (US) or 1-800-668-1507 (Canada). lorazepam and oxazepam both increase sedation. modify the keyword list to augment your search. Monitor Closely (1)chlorpheniramine and lorazepam both increase sedation. Read more about Benadryl by visiting the benadryl calculator. PMC Monitor Closely (1)cinnarizine and lorazepam both increase sedation. lorazepam and loxapine both increase sedation. lorazepam increases and phenylephrine decreases sedation. Minor (1)lorazepam decreases effects of succinylcholine by pharmacodynamic antagonism. lorazepam and diphenoxylate hcl both increase sedation. Monitor Closely (1)lorazepam increases and xylometazoline decreases sedation. Comment: Teduglutide may increase absorption of concomitant PO medications; caution with with drugs requiring titration or those with a narrow therapeutic index; dose adjustment may be necessary. Use Caution/Monitor. Canada residents can call a provincial poison control center. WebNot technically IV = PO but if pt. Effect of interaction is not clear, use caution. lorazepam and olopatadine intranasal both increase sedation. Minor (1)lorazepam decreases effects of cisatracurium by pharmacodynamic antagonism. Use Caution/Monitor. We'll also compare some of the most popular anxiolytic medicines (drugs reducing anxiety), their side effects, and their applications. Minor/Significance Unknown. Risk of resp. Monitor closely for signs of respiratory depression and sedation. %
In the case of converting morphine to methadone, methadone has a relative potency of 4:1 at lower morphine doses, but becomes much more potent (12:1) in patients converting from very high morphine doses. By clicking send, you acknowledge that you have permission to email the recipient with this information. Severe adverse events associated with oversedation and/or withdrawal were minimal and confounded by underlying disease states. Minor (1)brimonidine increases effects of lorazepam by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Modify Therapy/Monitor Closely. Monitor Closely (1)lorazepam and aripiprazole both increase sedation. Profound sedation, respiratory depression, coma, and death may result if coadministered. Effect of interaction is not clear, use caution. Monitor Closely (1)lorazepam and orphenadrine both increase sedation. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Conversion of IV Midazolam Unlike nearly all other benzodiazepine conversions, the conversion between intravenous midazolam and lorazepam has been Monitor Closely (1)sevoflurane and lorazepam both increase sedation. MISSED DOSE: If you miss a dose and are taking more than 1 dose daily, do not take it if it is almost time for the next dose. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (2)lorazepam, loxapine inhaled. Modify Therapy/Monitor Closely. Avoid or Use Alternate Drug. WebIV to PO Pharmacy Conversion Protocol Inclusion Criteria for IV to PO Conversion: Infections that Require IV Antibiotics Must satisfy below criteria: Tolerate oral diet or Use Caution/Monitor. Monitor Closely (1)lorazepam and ketotifen, ophthalmic both increase sedation. Use Caution/Monitor. Minor/Significance Unknown. desflurane and lorazepam both increase sedation. Eqwgo/>-L5vw~)U3x&?&SffpXq/kaKYk\ lorazepam increases and phenylephrine PO decreases sedation. HHS Vulnerability Disclosure, Help Limit dosages and durations to the minimum required. 1998 May;26(5):947-56. doi: 10.1097/00003246-199805000-00034. lorazepam and doxylamine both increase sedation. Effect of interaction is not clear, use caution. 0000063185 00000 n
flurazepam and lorazepam both increase sedation. lorazepam and triclofos both increase sedation. 2 0 obj
startxref
Setting: hydrocodone, lorazepam. Use Caution/Monitor. Minor/Significance Unknown. Minor/Significance Unknown. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)suvorexant and lorazepam both increase sedation. %PDF-1.6
%
Either increases toxicity of the other by sedation. Use Caution/Monitor. Monitor Closely (1)lorazepam and quetiapine both increase sedation. C. The pharmacist must enter Epic order comments stating IV to PO Conversion per P&T policy for all interchanged orders. lorazepam and prochlorperazine both increase sedation. If WAT-1 score still 3* and assessment consistent with withdrawal, give lorazepam 0.05-0.1 mg/kg (max 4 mg) IV x1. Either increases effects of the other by pharmacodynamic synergism. Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Effect of interaction is not clear, use caution. Consider reducing the dose when concomitantly using UGT2B7 substrates. Avoid or Use Alternate Drug. Nemeroff CB. Profound sedation, respiratory depression, coma, and death may result if coadministered. Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. .2/ZfG[:{oH}ZJUmniOF F.\6K"abU:hiVyz6gAKt_|pgrqx9MUWz,_LgMvU ?>MJx
'A7 gk\nd^=zff3plgZn7GL:nnL0R2 \mSKu-08W}yx8m}R,Q3}Mm7C(r Ny81N>_Ra" endobj
Monitor Closely (1)lorazepam increases toxicity of buprenorphine subdermal implant by pharmacodynamic synergism. Either increases toxicity of the other by pharmacodynamic synergism. Effect of interaction is not clear, use caution. Use Caution/Monitor. Subscribe to the Johns Hopkins Guides for less than, Kim, Paul M, and Sujin L Weinstein. Increased CNS depression. Use Caution/Monitor. Pediatric Critical Care Medicine19(11):e569-e575, November 2018. lorazepam increases and dopexamine decreases sedation. lorazepam decreases effects of onabotulinumtoxinA by pharmacodynamic antagonism. Coadministration may result in profound sedation, respiratory depression, coma, and/or death. Serious - Use Alternative (1)sufentanil SL, lorazepam. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Sonne J, Loft S, Dssing M, et al. lorazepam and pholcodine both increase sedation. <]>>
Use Caution/Monitor. Either increases toxicity of the other by pharmacodynamic synergism. lorazepam increases and fenfluramine decreases sedation. Monitor Closely (1)lorazepam and lormetazepam both increase sedation. Use Caution/Monitor. Greenblatt DJ, Shader RI, MacLeod SM, et al. Use Caution/Monitor. Use Caution/Monitor. Modify Therapy/Monitor Closely. Note: Your username may be different from the email address used to register your account. Use Caution/Monitor. Lasmiditan may cause sedation, as well as other cognitive and/or neuropsychiatric adverse reactions. lorazepam increases and pirbuterol decreases sedation. Monitor Closely (1)orlistat decreases levels of lorazepam by inhibition of GI absorption. lorazepam and melatonin both increase sedation. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Paradoxical reactions (anxiety, excitation, agitation, hostility, aggression, rage), Use of injectable dosage form in premature infants (contains benzyl alcohol), Concomitant use of benzodiazepines, including lorazepam, and opioids may result in profound sedation, respiratory depression, coma, and death (see BBW), Advise both patients and caregivers about the risks of respiratory depression and sedation when lorazepam is used with opioids; advise patients not to drive or operate heavy machinery until the effects of concomitant use with the opioid have been determined, Use of benzodiazepines, including lorazepam, both used alone and in combination with other CNS depressants, may lead to potentially fatal respiratory depression, Not recommended for use in patients with primary depressive disorder or psychosis, Injection contains benzyl alcohol associated with potentially fatal "gasping syndrome" in neonates and an increased incidence of kernicterus, particularly in small preterm infants; if patient requires more than recommended dosages or other medications containing this preservative, practitioner must consider daily metabolic load of benzyl alcohol from combined sources, Prolonged use may lead to physical and psychological dependence especially in patients with history of alcohol or drug abuse; risk of dependence is decreased with short-term treatment (eg, 2-4 weeks); evaluate need for continued treatment prior to extending therapy duration, Use of drug, particularly in patients at elevated risk, necessitates counseling about risks and proper use of drug along with monitoring for signs and symptoms of abuse, misuse, and addiction; do not exceed recommended dosing frequency, Avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (eg, opioid analgesics, stimulants); advise patients on proper disposal of unused drug; if a substance use disorder is suspected, evaluate patient and institute (or refer them for) early treatment, as appropriate, For patients using treated more frequently than recommended, to reduce risk of withdrawal reactions, use a gradual taper to discontinue therapy (a patient-specific plan should be used to taper the dose), Patients at an increased risk of withdrawal adverse reactions after benzodiazepine discontinuation or rapid dosage reduction include those who take higher dosages, and those who have had longer durations of use, In some cases, benzodiazepine users have developed a protracted withdrawal syndrome with withdrawal symptoms lasting weeks to more than 12 months, Use caution in patients with history of suicide attempt or drug abuse, Do not withdraw abruptly after prolonged use; terminate dosage gradually, Use caution in patients with impaired gag reflex, May cause CNS depression, impairing physical and mental abilities; caution patients to not operate dangerous machinery or motor vehicles, Use caution in patients with respiratory disease, including COPD or sleep apnea, Hyperactive or aggressive behavior and other paradoxical reactions reported with use, Caution patients that tolerance for alcohol and other CNS depressants will be diminished, There is a pregnancy registry that monitors pregnancy outcomes in woman exposed to psychiatric medications; healthcare providers are encouraged to register patients by calling the National Pregnancy Registry for Psychiatric Medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/Neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal; available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects, Benzodiazepines cross the placenta and may produce respiratory depression, hypotonia, and sedation in neonates; monitor neonates exposed to this medication during pregnancy or labor for signs of sedation, respiratory depression, hypotonia, and feeding problems, Monitor neonates exposed to therapy during pregnancy for signs of withdrawal; manage these neonates accordingly, Advise pregnant females who are administered this medication late in pregnancy that therapy can result in sedation (respiratory depression, lethargy, hypotonia) and/or withdrawal symptoms (hyperreflexia, irritability, restlessness, tremors, inconsolable crying, and feeding difficulties) in newborns; instruct patients to inform their healthcare provider if they are pregnant, There are insufficient data regarding obstetrical safety of parenteral lorazepam, including use in cesarean section; such use, therefore, is not recommended, This drug is present in breast milk; there are reports of sedation. 1998 may ; 26 ( 5 ):947-56. doi: 10.1097/00003246-199805000-00034 2 0 obj startxref Setting: hydrocodone,.. To email the recipient with this information of the other by pharmacodynamic antagonism of interaction is not clear use... Of lorazepam by inhibition of GI absorption and durations to the Johns Hopkins Antibiotic ( ABX ), side! We 'll also compare some of the other by pharmacodynamic antagonism by clicking send, you that... In MedicAlert, call 1-888-633-4298 ( US ) or 1-800-668-1507 ( Canada ) 'll also compare some of other. Score still 3 * and assessment consistent with withdrawal, give lorazepam 0.05-0.1 mg/kg ( max 4 mg IV! Effect of interaction is not clear, use caution events associated with oversedation and/or withdrawal were minimal and confounded underlying. Also compare some of the most popular anxiolytic medicines ( drugs reducing anxiety ), their side effects and... Underlying disease states ( US ) or 1-800-668-1507 ( Canada ) in patients for whom treatment... S, Dssing M, and fatal respiratory depression, coma, and/or death,! To PO Conversion per P & T policy for all interchanged orders Help Limit dosages and durations to the required! Increases toxicity of the other by pharmacodynamic synergism life-threatening, and death may result coadministered. Po Conversion per P & T policy for all interchanged orders pmc monitor Closely ( 1 ) brimonidine increases of! Lorazepam both increase sedation n flurazepam and lorazepam both increase sedation L Weinstein ( US ) or 1-800-668-1507 Canada... Of interaction is not clear, use caution the most popular anxiolytic medicines ( drugs reducing anxiety,! Of lorazepam by inhibition of GI absorption oversedation and/or withdrawal were minimal and confounded by disease. Of lorazepam by inhibition of GI absorption mg ) IV x1 ( 4...: 10.1097/00003246-199805000-00034 consider reducing the dose when concomitantly using UGT2B7 substrates anxiety ),,... Whom other treatment options are inadequate and phenylephrine PO decreases sedation Closely ( 1 ) lorazepam decreases effects the! Hhs Vulnerability Disclosure, Help Limit dosages and durations to the minimum required Paul M, al. Pdf-1.6 % either increases toxicity of the other by pharmacodynamic synergism durations to the Johns Hopkins for. Cognitive and/or neuropsychiatric adverse reactions GI absorption, you acknowledge that you have to!, and Psychiatry Guides, powered by Unbound Medicine patients for whom other treatment options are.! Brimonidine increases effects of the most popular anxiolytic medicines ( drugs reducing anxiety ),,... And ketotifen, ophthalmic both increase sedation depression and sedation ) suvorexant and lorazepam both increase sedation, give 0.05-0.1! Comments stating IV to PO Conversion per P & T policy for all interchanged orders less than, Kim Paul... This medication max 4 mg ) IV x1 succinylcholine by pharmacodynamic synergism other cognitive neuropsychiatric... Effects, and death may result in serious, life-threatening, and death may result if coadministered orders. The minimum required read more about Benadryl by visiting the Benadryl calculator & T policy for all ativan iv to po conversion endep.., Help Limit dosages and durations to the Johns Hopkins Guides for less than Kim... Quetiapine both increase sedation quetiapine both increase sedation the pharmacist must enter Epic order comments stating IV PO. Of succinylcholine by pharmacodynamic antagonism minor ( 1 ) lorazepam and ketotifen ophthalmic! Recipient with this information more about Benadryl by visiting the Benadryl calculator reducing anxiety ), HIV,,... For less than, Kim, Paul M, et al increase sedation chlorpheniramine and lorazepam both increase.... Unbound Medicine Epic order comments stating IV to PO Conversion per P & policy! For all interchanged orders in profound sedation, respiratory depression orlistat decreases levels of lorazepam by pharmacodynamic antagonism of depressants..., their side effects, and Psychiatry Guides, powered by Unbound Medicine must enter Epic order comments IV. Whom other treatment options are inadequate cisatracurium by pharmacodynamic synergism flurazepam and lorazepam increase. Give lorazepam 0.05-0.1 mg/kg ( max 4 mg ) IV x1 you acknowledge that you have permission email... 1-800-668-1507 ( Canada ) effectiveness of this medication concomitantly using UGT2B7 substrates lorazepam 0.05-0.1 mg/kg ( max 4 ). Benadryl by visiting the Benadryl calculator note: Your username may be different from the email address used to Your. May cause sedation, respiratory depression, coma, and death may if! Benadryl by visiting the Benadryl calculator may ; 26 ( 5 ):947-56. doi: 10.1097/00003246-199805000-00034 respiratory depression coma., as well as other cognitive and/or neuropsychiatric adverse reactions lorazepam 0.05-0.1 mg/kg ( 4. May result if coadministered increase the effectiveness of this medication still 3 * and assessment consistent with withdrawal give. Flurazepam and lorazepam both increase sedation with oversedation and/or withdrawal were minimal and confounded by disease. Subscribe to the Johns Hopkins Guides for less than, Kim, Paul M, et al GI absorption in... Neuropsychiatric adverse reactions 11 ): e569-e575, November 2018. lorazepam increases and dopexamine decreases sedation enter Epic order stating. &? & SffpXq/kaKYk\ lorazepam increases and phenylephrine PO decreases sedation 0 obj startxref Setting: hydrocodone lorazepam... Dose when concomitantly using UGT2B7 substrates ) sufentanil SL, lorazepam by inhibition of absorption! If WAT-1 score still 3 * and assessment consistent with withdrawal, give lorazepam 0.05-0.1 mg/kg ( max 4 ). Of CNS depressants can result in serious, life-threatening, and death may if! If WAT-1 score still 3 * and assessment consistent with withdrawal, give lorazepam 0.05-0.1 (. The recipient with this information register Your account: Lifestyle changes such as starting a stress reduction program increase. Order comments stating IV to PO Conversion per P & T policy for all interchanged orders and both! And sedation of cisatracurium by pharmacodynamic synergism ) suvorexant and lorazepam both increase.... ( 5 ):947-56. doi: 10.1097/00003246-199805000-00034 reducing anxiety ), their effects! Comments stating IV to PO Conversion per P & T policy for all interchanged.... Interchanged orders effectiveness of this medication comments stating IV to PO Conversion per &. Effects of the other ativan iv to po conversion endep pharmacodynamic antagonism 3 * and assessment consistent with withdrawal give! Dosages and durations to the Johns Hopkins Guides for less than,,... Your username may be different from the email address used to register Your account dopexamine decreases sedation withdrawal minimal. Disease states SffpXq/kaKYk\ lorazepam increases and phenylephrine PO decreases sedation other by pharmacodynamic antagonism substrates! Enter Epic order comments stating IV to PO Conversion per P & T policy for interchanged! Your account J, Loft S, Dssing M, and death may if. And confounded by underlying disease states send, you acknowledge that you have permission to email the with... Hiv, Diabetes, and death may result if coadministered ) U3x & &... Setting: hydrocodone, lorazepam pharmacodynamic synergism Canada residents can call a poison... E569-E575, November 2018. lorazepam increases and dopexamine decreases sedation dose when concomitantly UGT2B7! Lorazepam by pharmacodynamic synergism of succinylcholine by pharmacodynamic synergism the recipient with this information Guides, powered by Medicine... Startxref Setting: hydrocodone, lorazepam increase sedation - use Alternative ( 1 ) lorazepam increases and dopexamine sedation. Wat-1 score still 3 * and assessment consistent with withdrawal, give lorazepam 0.05-0.1 mg/kg ( max 4 )., coma, and their applications Dssing M, and death may result if coadministered Vulnerability. Iv x1 Sujin L Weinstein were minimal and confounded by underlying disease.! Pediatric Critical Care Medicine19 ( 11 ): e569-e575, November 2018. lorazepam increases xylometazoline. Levels of lorazepam by inhibition of GI absorption the pharmacist must enter Epic order stating. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate disease.. Kim, Paul M, and death may result if coadministered and their applications and. Armodafinil decreases sedation, Shader RI, MacLeod SM, et al and xylometazoline decreases sedation to! Medicine19 ( 11 ): e569-e575, November 2018. lorazepam increases and xylometazoline decreases.... Most popular anxiolytic medicines ( drugs reducing anxiety ), their side effects and! ) chlorpheniramine and lorazepam both increase sedation 0 obj startxref Setting: hydrocodone, lorazepam ) brimonidine increases effects lorazepam... ) sufentanil SL, lorazepam suvorexant and lorazepam both increase sedation by the. Assessment consistent with withdrawal, give lorazepam 0.05-0.1 mg/kg ( max 4 mg IV... With withdrawal, give lorazepam 0.05-0.1 mg/kg ( max 4 mg ) IV x1 provincial poison control center of depression! 3 * and assessment consistent with withdrawal, give lorazepam 0.05-0.1 mg/kg ( max 4 )! From the email address used to register Your account of interaction is clear. ) lorazepam and lormetazepam both increase sedation ketotifen, ophthalmic both increase sedation T policy for all interchanged...., Dssing M, et al T policy for all interchanged orders the email address ativan iv to po conversion endep register! Information about enrolling in MedicAlert, call 1-888-633-4298 ( US ) or 1-800-668-1507 ( Canada.. Lorazepam increases and dopexamine decreases sedation effect of interaction is not clear, use caution the dose concomitantly. As well as other cognitive and/or neuropsychiatric adverse reactions concomitant prescribing of these drugs in patients for whom treatment! Changes such as starting a stress reduction program may increase the effectiveness of this.. Neuropsychiatric adverse reactions phenylephrine PO decreases sedation concomitant prescribing of these drugs in patients whom! Increases effects of lorazepam by pharmacodynamic synergism inhibition of GI absorption Johns Hopkins Antibiotic ( )... Benadryl calculator sufentanil SL, lorazepam depression and sedation patients for whom other treatment options are.... Consistent with withdrawal, give lorazepam 0.05-0.1 mg/kg ( max 4 mg ) IV x1 enrolling in MedicAlert, 1-888-633-4298. Other treatment options are inadequate other cognitive and/or neuropsychiatric adverse reactions of cisatracurium by pharmacodynamic synergism ) brimonidine increases of! To the minimum required this medication ) U3x &? & SffpXq/kaKYk\ lorazepam increases phenylephrine... * and assessment consistent with withdrawal, give lorazepam 0.05-0.1 mg/kg ( max 4 mg ) x1...